Photo

Photo detail

Stories this photo appears in:

Kite Cleared to Market Cancer Treatment in EU

Santa Monica-based pharmaceutical company Kite was granted conditional marketing authorization within the European Union for its new drug Tecartus, which is used to treat a rare form of lymphoma.

Tease photo